Diagnostic pitfalls of drug-induced immune hemolytic anemia
Paid access
|Nov 2019References
- Salama A, Mueller-Eckhardt C, Kissel K, Pralle H, Seeger W. Ex vivo antigen preparation for the serological detection of drug-dependent antibodies in immune haemolytic anaemias. Br J Haematol 1984;58:525–31.
- Yürek S, Riess H, Kreher S, Dörken B, Salama A. Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil. Transfus Med 2010;20:265–8.
- Salama A. Drug-induced immune hemolytic anemia. In: Sipes IG, McQueen CA, Gandolfi AJ, eds. Comprehensive toxicology. Vol 4. 1st ed. New York, NY: Pergamon, 1997:73–85.
- Salama A. Drug-induced immune hemolytic anemia. Expert Opin Drug Saf 2009;8:73–9.
- Garratty G. Immune hemolytic anemia caused by drugs. Expert Opin Drug Saf 2012;11:635–42.
- Ahrens N, Genth R, Salama A. Belated diagnosis in three patients with rifampicin-induced immune haemolytic anaemia. Br J Haematol 2002;117:441–3.
- Shirey R, Iding J, King KE, Ness PM. Drug-induced immune hemolysis mimicking an acute hemolytic transfusion reaction [abstract]. Transfusion 2005;45:100A–1A.
- Shirey R, Yamada C, Ness PM, King KE. Drug-induced immune hemolytic anemia imitating a severe delayed hemolytic transfusion reaction [abstract]. Transfusion 2007;47:185A.
- Stroncek D, Procter JL, Johnson J. Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction. Am J Hematol 2000;64:67–70.
- Leaf DE, Langer NB, Markowski M, Garratty G, Diuguid DL. A severe case of cefoxitin-induced immune hemolytic anemia. Acta Haematol 2010;124:197–9.
- Gupta S, Piefer CL, Fueger JT, Johnson ST, Punzalan RC. Trimethoprim-induced immune hemolytic anemia in a pediatric oncology patient presenting as an acute hemolytic transfusion reaction. Pediatr Blood Cancer 2010;55:1201–3.
- Arndt P, Garratty G, Isaak E, Bolger M, Lu Q. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption. Transfusion 2009;49:711–18.
- Salama A, Berghöfer H, Mueller-Eckhardt C. Detection of cell-drug (hapten)-antibody complexes by the gel test. Transfusion 1992;32:554–6.
- Salama A, Mueller-Eckhardt C. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine. Blood 1986;68:1285–8.
- Salama A, Mueller-Eckhardt C. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med 1985;313:469–74.
- Salama A, Kroll H, Wittmann G, Mueller-Eckhardt C. Diclofenac-induced immune haemolytic anaemia: simultaneous occurrence of red blood cell autoantibodies and drug-dependent antibodies. Br J Haematol 1996;95:640–4.
- Bougie D, Johnson ST, Weitekamp LA, Aster RH. Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia. Blood 1997;90:407–13.
- Mayer B, Leo A, Herziger A, Houben P, Schemmer P, Salama A. Intravascular immune hemolysis caused by the contrast medium iomeprol. Transfusion 2013;53:2141–4.
DOI: https://doi.org/10.21307/immunohematology-2019-101 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 80 - 84
Published on: Nov 6, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2019 A. Salama, B. Mayer, published by American National Red Cross
This work is licensed under the Creative Commons License.